Hullinger TG[au] - Search Results

Year	Number of Results
1993	2
1994	2
1996	1
1998	1
2000	2
2001	2
2004	1
2011	2
2012	1
2013	1
2023	0

1

Inhibition of miR-15 protects against cardiac ischemic injury.

Hullinger TG, Montgomery RL, Seto AG, Dickinson BA, Semus HM, Lynch JM, Dalby CM, Robinson K, Stack C, Latimer PA, Hare JM, Olson EN, van Rooij E. Hullinger TG, et al. Circ Res. 2012 Jan 6;110(1):71-81. doi: 10.1161/CIRCRESAHA.111.244442. Epub 2011 Nov 3. Circ Res. 2012. PMID: 22052914 Free PMC article.

2

Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.

Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN, van Rooij E. Montgomery RL, et al. Among authors: hullinger tg. Circulation. 2011 Oct 4;124(14):1537-47. doi: 10.1161/CIRCULATIONAHA.111.030932. Epub 2011 Sep 6. Circulation. 2011. PMID: 21900086 Free PMC article.

3

N-linked sialyated sugar receptors support haematopoietic cell-osteoblast adhesions.

Crean SM, Meneski JP, Hullinger TG, Reilly MJ, DeBoever EH, Taichman RS. Crean SM, et al. Among authors: hullinger tg. Br J Haematol. 2004 Feb;124(4):534-46. doi: 10.1046/j.1365-2141.2003.04786.x. Br J Haematol. 2004. PMID: 14984505 Free article.

4

Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure.

Dickinson BA, Semus HM, Montgomery RL, Stack C, Latimer PA, Lewton SM, Lynch JM, Hullinger TG, Seto AG, van Rooij E. Dickinson BA, et al. Among authors: hullinger tg. Eur J Heart Fail. 2013 Jun;15(6):650-9. doi: 10.1093/eurjhf/hft018. Epub 2013 Feb 6. Eur J Heart Fail. 2013. PMID: 23388090 Free article.

5

Effect of bone proteins on human prostate cancer cell lines in vitro.

Hullinger TG, McCauley LK, DeJoode ML, Somerman MJ. Hullinger TG, et al. Prostate. 1998 Jun 15;36(1):14-22. doi: 10.1002/(sici)1097-0045(19980615)36:1<14::aid-pros3>3.0.co;2-b. Prostate. 1998. PMID: 9650911 Free article.

6

In vivo validation of a transit-time ultrasonic volume flow meter.

Hartman JC, Olszanski DA, Hullinger TG, Brunden MN. Hartman JC, et al. Among authors: hullinger tg. J Pharmacol Toxicol Methods. 1994 Jun;31(3):153-60. doi: 10.1016/1056-8719(94)90078-7. J Pharmacol Toxicol Methods. 1994. PMID: 8068977

7

Secretory products from PC-3 and MCF-7 tumor cell lines upregulate osteopontin in MC3T3-E1 cells.

Hullinger TG, Taichman RS, Linseman DA, Somerman MJ. Hullinger TG, et al. J Cell Biochem. 2000 Jun 12;78(4):607-16. doi: 10.1002/1097-4644(20000915)78:4<607::aid-jcb10>3.0.co;2-f. J Cell Biochem. 2000. PMID: 10861858 Free article.

8

TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements.

Hullinger TG, Pan Q, Viswanathan HL, Somerman MJ. Hullinger TG, et al. Exp Cell Res. 2001 Jan 1;262(1):69-74. doi: 10.1006/excr.2000.5074. Exp Cell Res. 2001. PMID: 11120606

9

Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.

Hartman JC, Wall TM, Hullinger TG, Shebuski RJ. Hartman JC, et al. Among authors: hullinger tg. J Cardiovasc Pharmacol. 1993 Jun;21(6):996-1003. doi: 10.1097/00005344-199306000-00022. J Cardiovasc Pharmacol. 1993. PMID: 7687728

10

p21-activated kinase-1 (PAK1) inhibition of the human scavenger receptor class B, type I promoter in macrophages is independent of PAK1 kinase activity, but requires the GTPase-binding domain.

Hullinger TG, Panek RL, Xu X, Karathanasis SK. Hullinger TG, et al. J Biol Chem. 2001 Dec 14;276(50):46807-14. doi: 10.1074/jbc.M103176200. Epub 2001 Oct 3. J Biol Chem. 2001. PMID: 11585816 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results